Taxotere®

Permanent Hair Loss And Taxotere

You won your battle with breast cancer,
and yet every day you face a reminder of what you lost.

Permanent Hair Loss And Taxotere

You won your battle with breast cancer,
and yet every day you face a reminder of what you lost.

Are you, a family member or a friend dealing with permanent hair loss after surviving breast cancer?

Were you treated with chemotherapy drug Taxotere®?

You should know, Taxotere® may be the cause of permanent hair loss.

CALL TODAY to get your case started.
(800) 600- 6014

Start your Free Consultation

* Name:

* Email:

Phone:

* Case Details:

*Required Fields

What is Taxotere®?

Taxotere®, generically named Docetaxel, is an anti-cancer chemotherapy drug approved for the treatment of different kinds of cancer, including breast cancer. Taxotere® is manufactured by Sanofi™ and was first approved by the U.S. Food and Drug Administration (FDA) in 1996 for the treatment of metastic breast cancer.

Why Taxotere® Is Defective?

Although, temporary hair loss may be a possible side effect of chemotherapy, an alarming number of research studies show that Taxotere® can be linked to permanent hair loss. Researchers at the National Cancer Conference reported in 2014 that permanent hair loss was a side effect in 10-15% of chemotherapy patients who took Taxotere®.

Furthermore, a study by the Annals of Oncology, noted Taxotere®’s devastating effect on a patient’s quality of life.

At Goldberg Attorneys, we truly understand how devastating permanent hair loss can be.  Our law firm is here to help you.  Call us today to find out if you have claim. 

LEARN MORE

about Taxotere® and its effects today.